Globally.
Our headquarters are located in Pittsburgh, Pennsylvania’s tech and innovation corridor.
Our cervical cancer research programs include El Salvador, China, Colombia, Haiti, Dominican Republic, Guatemala, Peru, and Paraguay.
Research sites for our COVID-19 test validation include El Salvador, Malawi, Nigeria, Paraguay, with a forthcoming US site.